Zhitong A Share Sale Restriction and Release List | June 13

On June 13th, a total of 8 listed companies had their restricted stocks lifted, with a total market value of about 3.163 billion yuan. The specific situation of restricted stock lifting today is as follows: stock abbreviation, stock code, type of restricted stock, number of lifted shares: China Reform Health Management and Services Group (000503), A-share issued by additional public offering for corporate allocation, 56.2893 million shares; Gansu Energy Chemical (000552), A-share issued by additional public offering for corporate allocation, 741 million shares; Aluminum Corporation of China (601600), stock-based incentive restricted circulation, 43.7442 million; Sanxiang Advanced Materials (603663), stock-based incentive restricted circulation, 535,100 shares; Rontec Co., Ltd. (605133), stock-based incentive restricted circulation, 624,900 shares.

Zhitong FinanceJun 12 21:00 ET

China Reform Health Management and Services Group (stock code 000503.SZ): 56.2893 million restricted shares will be listed for circulation on June 13, accounting for 5.72% of the total share capital.

China Reform Health Management and Services Group (000503.SZ) announced that the company will lift restrictions on 56.2893 million shares, representing 5.72% of the total share capital. The unrestricted shares will be listed and traded on June 13, 2024.

Zhitong FinanceJun 6 06:44 ET

Is China Reform Health Management and Services Group (SZSE:000503) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious

Simply Wall StMay 22 18:03 ET

Guoxin Health (000503.SZ): Net loss of 40.3818 million yuan in the first quarter

Gelonghui, April 26 | Guoxin Health (000503.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 479.155 million yuan, down 14.08% year on year; net profit attributable to shareholders of listed companies - 40,3818 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 405.24,900 yuan; basic earnings per share - 0.0412 yuan.

Gelonghui FinanceApr 26 05:47 ET

Guoxin Health (000503.SZ): 2023 pre-loss of about RMB 80.45 million

Gelonghui, January 29丨Guoxin Health (000503.SZ) announced its 2023 annual results forecast. The net profit loss attributable to shareholders of listed companies during the reporting period was approximately RMB 80.45 million, with a loss of 84.47 million yuan during the same period of the previous year; net profit loss after deducting non-recurring profit and loss of about RMB 123.46 million, loss of 117.81 million yuan for the same period last year; basic earnings loss per share was about 0.0883 million yuan per share; operating income was approximately RMB 31.08 million after deduction. During the reporting period, the company firmly established a “two wings in one” strategic layout, on the one hand

Gelonghui FinanceJan 29 03:22 ET

Guoxin Health (000503.SZ): Chairman Yang Dianzhong resigns

Gelonghui, December 29 | Guoxin Health (000503.SZ) announced that the board of directors of the company recently received a written resignation report submitted by Mr. Yang Dianzhong, the chairman of the company. Mr. Yang Dianzhong applied to resign as a director and chairman of the company due to personal reasons. After resigning from the above positions, he did not work for the company or its holding subsidiaries.

Gelonghui FinanceDec 29, 2023 03:46 ET